Project Grant K23NR021034
- This Project Grant award from the U.S. Department of Health and Human Services' National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $1,072,621 to Duke University to conduct an adequately powered randomized controlled trial of a multi-component lifestyle intervention aimed at improving blood pressure control and cardiovascular outcomes in Black adults with chronic kidney disease (CKD). The goal is to evaluate the impact of lifestyle modifications,...
- This federal Project Grant award, valued at $209,832.00 and provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, will support research at New York University (NYU) to improve the understanding of the role of the autonomic nervous system (ANS) in the cardiovascular complications of chronic kidney disease (CKD). The 5-year project aims to develop the candidate's skills in ANS...
- This Project Grant award, valued at $199,130.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective is to demonstrate the clinical utility of patient-reported outcome measures (PROMs) in the care of individuals with advanced chronic kidney disease (CKD). The award will fund research across two key areas: 1) developing and validating risk...
- This $192,215 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support a research project titled "Assessing Patient-Centric Factors and Enhancing Risk Communication to Improve Treatment Persistence in Kidney and Cardiovascular Care" at the University of California, San Francisco (UCSF). The project aims to develop an effective risk communication aid to...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000.00 to New York University School of Medicine to conduct a case-cohort study investigating novel determinants of risk for living kidney donors. The key objectives are to: 1) use qualitative research to inform recruitment strategies and messaging to maximize participation of...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research Program (CFDA 93.847), awarded a $671,986 Project Grant to Rutgers, The State University of New Jersey, to conduct research aimed at strengthening the evidence-base for medication prescribing in older adults with chronic kidney disease (CKD). The key objectives of the 4-year project are to: 1) evaluate the effectiveness of renoprotective therapies...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $193,809 to Yale University to assess the efficacy of sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of acute cardiorenal syndrome. The candidate, an Instructor of Medicine (Nephrology) with 3 years of training in acute kidney injury and clinical trials,...
- This $166,740 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to conduct research on the role of urinary phosphate in the progression of chronic kidney disease (CKD). The key activities under this 5-year award include: Defining how chronic phosphaturia (high urinary phosphate levels) impacts CKD progression in a mouse model. Determining if enhancing tubular phosphate...
- This federal Project Grant award of $330,997.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a study on a remote home-based rehabilitation intervention for kidney transplant candidates. The University of Pennsylvania will conduct this research project with the goal of improving physical activity, function, and reducing frailty in kidney transplant...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $165,899 to New York University (NYU) for a small-scale pilot randomized controlled trial of a supportive care intervention called "Project ANCHOR" for caregivers of patients awaiting kidney transplantation. The intervention will use a telehealth coaching approach to...
AN INTERVENTION TO REDUCE SEDENTARY BEHAVIOR FOR BLACK ADULTS WITH CHRONIC KIDNEY DISEASE: RESET-CKD - PROJECT SUMMARY THE PURPOSE OF THIS K23 MENTORED PATIENT-ORIENTED CAREER DEVELOPMENT AWARD APPLICATION IS TO SUPPORT THE APPLICANT'S LONG-TERM GOAL TO DEVELOP AN INDEPENDENT RESEARCH PROGRAM FOCUSED ON IMPROVING THE HEALTH AND QUALITY OF LIFE FOR ADULTS WITH CHRONIC KIDNEY DISEASE (CKD) THROUGH HEALTHY LIFESTYLE BEHAVIORS, WITH A PARTICULAR FOCUS ON UNDERREPRESENTED MINORITY POPULATIONS. BLACK ADULTS ARE DISPROPORTIONATELY AFFECTED BY CKD AND HAVE SOME OF THE WORST HEALTH OUTCOMES AMONG THOSE WITH CKD. ADULTS WITH CKD ARE EXTREMELY SEDENTARY, AND THE POOR HEALTH OUTCOMES ASSOCIATED WITH CKD MAY BE MODIFIABLE BY ADDRESSING SEDENTARY BEHAVIOR- A LIFESTYLE BEHAVIOR ASSOCIATED WITH ADVERSE HEALTH CONSEQUENCES. THEORY-BASED BEHAVIORAL INTERVENTIONS CAN EFFECTIVELY REDUCE SEDENTARY TIME, BUT RESEARCH IS LACKING ON THEORY-BASED SEDENTARY REDUCING INTERVENTIONS ADAPTED TO MEET THE UNIQUE NEEDS OF THE AT-RISK POPULATION OF BLACK ADULTS WITH CKD. THE OVERALL GOAL OF THIS AWARD IS TO ADAPT AN EVIDENCED-BASED INTERVENTION TO REDUCE SEDENTARY TIME FOR BLACK ADULTS WITH CKD GUIDED BY PATIENT- CENTERED DESIGN. DURING AIM 1, AN EVIDENCED-BASED SEDENTARY REDUCING INTERVENTION WILL BE ADAPTED TO ADDRESS UNIQUE FACTORS THAT INFLUENCE SEDENTARY BEHAVIOR FOR BLACK ADULTS WITH CKD. ADAPTATION OF THE INTERVENTION WILL BE LED BY A PATIENT ADVISORY BOARD COMPRISED OF BLACK ADULTS WITH CKD. IN AIM 2, WE WILL CONDUCT A 12-WEEK PILOT RANDOMIZED CONTROLLED TRIAL OF THE ADAPTED INTERVENTION (RESET-CKD) TO REDUCE SEDENTARY TIME FOR BLACK ADULTS WITH CKD. IN AIM 3, WE WILL EXPLORE THE LIVED EXPERIENCE OF THE RESET-CKD INTERVENTION PARTICIPANTS AND IDENTIFY BARRIERS AND FACILITATORS TO REDUCING SEDENTARY TIME. THESE FINDINGS WILL BE USED TO INFORM THE DEVELOPMENT OF THE EFFICACY TRIAL THAT WILL FOLLOW THIS K23 AWARD. THIS PROPOSAL ALIGNS WITH THE NATIONAL INSTITUTE OF NURSING RESEARCH'S (NINR) MISSION TO PROMOTE HEALTH EQUITY BY ADDRESSING THE HEALTH OUTCOME INEQUITIES EXPERIENCED BY BLACK ADULTS WITH CKD BY ADAPTING A SEDENTARY REDUCING INTERVENTION TO MEET THE NEEDS OF BLACK ADULTS WITH CKD. UNDER THE GUIDANCE OF THE MULTIDISCIPLINARY MENTORING TEAM, THE APPLICANT WILL RECEIVE TRAINING IN HEALTH DISPARITIES AND HEALTH EQUITY RESEARCH, CLINICAL TRIAL DESIGN, AND MIXED METHODS TO CONDUCT THIS INNOVATIVE WORK AND EXPAND THE APPLICANT'S PROGRAM OF RESEARCH. COMPLETION OF THIS PROPOSAL WILL GENERATE DATA TO SUPPORT AN R01 APPLICATION TO CONDUCT A LARGE, RANDOMIZED CONTROLLED INTERVENTION TO DECREASE SEDENTARY TIME AND IMPROVE OUTCOMES IN BLACK ADULTS WITH CKD. THIS K23 AWARD WILL SUPPORT THE CANDIDATE'S CAREER DEVELOPMENT AS A NURSE SCIENTIST BY CONDUCTING MENTORED RESEARCH FOCUSED ON DECREASING SEDENTARY BEHAVIOR FOR BLACK ADULTS WITH CKD IN THE CONTEXT OF THE NINR HEALTH EQUITY RESEARCH LENS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $173.5k | 7/8/25 | ||
| Not listed | $175.6k | 7/16/24 |